Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 535 patients

JAMA Surgery

Volumn 150, Issue 6, 2015, Pages 538-545

  Spolverato, Gaya ^a   Kim, Yuhree ^a   Ejaz, Aslam ^a   Alexandrescu, Sorin ^b   Marques, Hugo ^c   Aldrighetti, Luca ^d   Gamblin, T Clark ^e   Pulitano, Carlo ^f   Bauer, Todd W ^g   Shen, Feng ^h   Sandroussi, Charbel ^f   Poultsides, George ⁱ   Maithel, Shishir K ^j   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Institute for Digestive Diseases and Liver Transplantation Fundeni   (Romania)

^c HOSPITAL CURRY CABRAL   (Portugal)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF VIRGINIA   (United States)

^h Eastern Hepatobiliary Surgery Hospital   (China)

ⁱ STANFORD UNIVERSITY   (United States)

^j EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMIHEPATECTOMY; HUMAN; LIVER CIRRHOSIS; LIVER RESECTION; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR INVASION; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CLINICAL TRIAL; INTRAHEPATIC BILE DUCT; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84934270604     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.0219     Document Type: Article

References (35)

1. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans. Hepatology. 2009;49(1):116-123.
2. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84-96.
3. Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol. 2006;45(6):856-867.
4. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40(3):472-477.
5. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98(12):873-875.
6. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):77-82.
7. Carpizo DR, D'Angelica M. Management and extent of resection for intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2009;18(2):289-305, viii-ix.
8. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33(6):1353-1357.
9. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):115-125.
10. De Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140-3145.
11. Hyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg. 2014;149(5):432-438.
12. Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis [published online April 9, 2014]. JAMA Surg. doi:10.1001/jamasurg.2013.5137.
13. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
14. Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188-1195.
15. Nathan H, De Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg. 2010;210(5):755-764, 764-766.
16. Henson DE, Ries LA, Carriaga MT. Conditional survival of 56, 268 patients with breast cancer. Cancer. 1995;76(2):237-242.
17. Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34, 963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998;41(9):1097-1106.
18. Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol. 2003;21(16):3035-3040.
19. Sun M, Trinh QD, Karakiewicz PI. Conditional survival of patients with metastatic renal-cell carcinoma. Lancet Oncol. 2012;13(11):e462.
20. Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer. 2007;10(3):153-158.
21. Mayo SC, Nathan H, Cameron JL, et al. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012;118(10):2674-2681.
22. Cucchetti A, Piscaglia F, Cescon M, et al. Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Clin Cancer Res. 2012;18(16):4397-4405.
23. Eloranta S, Lambert PC, Andersson TM, Björkholm M, Dickman PW. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival. Epidemiology. 2014;25(5):742-748.
24. Daudt HM, Van Mossel C, Dennis DL, Leitz L, Watson HC, Tanliao JJ. Survivorship care plans: a work in progress. Curr Oncol. 2014;21(3):e466-e479.
25. Burnand B, Kernan WN, Feinstein AR. Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol. 1990;43(12):1273-1284.
26. Spolverato G, Ejaz A, Kim Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2014;18(7):1284-1291.
27. Janssen-Heijnen ML, Gondos A, Bray F, et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol. 2010;28(15):2520-2528.
28. Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist. 2010;15(8):873-882.
29. Johnson DR, Ma DJ, Buckner JC, Hammack JE. Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012;118(22):5608-5613.
30. Morimoto Y, Tanaka Y, Ito T, et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10(6):432-440.
31. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y, Furukawa M. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg. 2001;181(6):507-511.
32. Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol. 2009;16(11):3048-3056.
33. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89(12):1525-1531.
34. Li T, Qin LX, Zhou J, et al. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Liver Int. 2014;34(6):953-960.
35. Janssen-Heijnen ML, Houterman S, Lemmens VE, Brenner H, Steyerberg EW, Coebergh JW. Prognosis for long-term survivors of cancer. Ann Oncol. 2007;18(8):1408-1413.